参考文献:1. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364(9434):613鈥?0. 55-4" target="_blank" title="It opens in new window">CrossRef 2. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775鈥?9. 56/NEJMoa063070" target="_blank" title="It opens in new window">CrossRef 3. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543鈥?4. 56/NEJMoa0805800" target="_blank" title="It opens in new window">CrossRef 4. Ingebrigtsen TS, Marott JL, Vestbo J, et al. Characteristics of undertreatment in COPD in the general population. Chest. 2013;144(6):1811鈥?. 53" target="_blank" title="It opens in new window">CrossRef 5. Fitch K, Iwasaki K, Pyenson B, Plauschinat C, Zhang J. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis. Curr Med Res Opin. 2011;27(7):1425鈥?. 5/03007995.2011.583230" target="_blank" title="It opens in new window">CrossRef 6. Krigsman K, Nilsson JL, Ring L. Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiol Drug Saf. 2007;16(4):441鈥?. CrossRef 7. Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939鈥?3. CrossRef 8. Bryant J, McDonald VM, Boyes A, Sanson-Fisher R, Paul C, Melville J. Improving medication adherence in chronic obstructive pulmonary disease: a systematic review. Respir Res. 2013;14(1):109. 5-9921-14-109" target="_blank" title="It opens in new window">CrossRef 9. Thomsen M, Ingebrigtsen TS, Marott JL, et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA. 2013;309(22):2353鈥?1. 5732" target="_blank" title="It opens in new window">CrossRef 10. Vestbo J, Hurd SS, Agust铆 AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347鈥?5. 596PP" target="_blank" title="It opens in new window">CrossRef 11. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull. 1997;44(4):445鈥?. 12. The Danish National Patient Register. Available at: http://www.ssi.dk/Sundshedsdataogit/Registre/Landspatientregisteret.aspx. Accessed July 18, 2014. 13. Kozma CM, Dickson M, Phillips AL, Meletiche DM. Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis. Patient Prefer Adherence. 2013;7:509鈥?6. CrossRef 14. WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health. List of DDDs combined products. Available at: http://www.whocc.no/ddd/list_of_ddds_combined_products/. Accessed July 18, 2014. 15. WHO Collaborating Centre for Drug Statistics Methodology. Available at: http://www.whocc.no. Accessed July 18, 2014. 16. The Comprehensive R Archive Network: Available at: http://cran.r-project.org/. Accessed July 18, 2014. 17. Crawley M, The R. book. Imperial College London at Silwood Park. John Wiley & Sons: London, UK; 2007. 18. Yang Y, Thumula V, Pace PF, Banahan BF 3rd, Wilkin NE, Lobb WB. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study. Clin Ther. 2009;31(10):2178鈥?8. discussion 2150鈥?. CrossRef 19. Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3(3):371鈥?4. 20. Laforest L, Denis F, Van Ganse E, et al. Correlates of adherence to respiratory drugs in COPD patients. Prim Care Respir J. 2010;19(2):148鈥?4. CrossRef 21. Touchette DR, Shapiro NL. Medication Compliance, Adherence, and Persistence: Current Status of Behavioral and Educational Interventions to Improve Outcomes. J Manag Care Pharm. 2008;14(6):S2鈥揝10. 22. Khdour MR, Hawwa AF, Kidney JC, Smyth BM, McElnay JC. Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol. 2012;68(10):1365鈥?3. 5" target="_blank" title="It opens in new window">CrossRef 23. Cabana MD, Rand CS, Powe NR, et al. Why don鈥檛 physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458鈥?5. 5.1458" target="_blank" title="It opens in new window">CrossRef 24. Lange P, Marott JL, Vestbo J, Ingebrigtsen TS, Nordestgaard BG. Socioeconomic Status and Prognosis of COPD in Denmark. COPD. 2014. 25. Huetsch JC, Uman JE, Udris EM, Au DH. Predictors of adherence to inhaled medications among Veterans with COPD. J Gen Intern Med. 2012;27(11):1506鈥?2. 5" target="_blank" title="It opens in new window">CrossRef 26. VanderSchaaf K, Olson KL, Billups S, Hartsfield CL, Rice M. Self-reported inhaler use in patients with chronic obstructive pulmonary disease. Respir Med. 2010;104(1):99鈥?06. CrossRef 27. Sode BF, Dahl M, Nordestgaard BG. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. Eur Heart J. 2011;32(19):2365鈥?5. CrossRef 28. Hill K, Goldstein RS, Guyatt GH, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010;182(7):673鈥?. 503/cmaj.091784" target="_blank" title="It opens in new window">CrossRef 29. Statistics from Statens Serum Institut (sale of drugs in Denmark during 1996鈥?013). Available at: www.medstat.dk. Accessed July 18, 2014. 30. Hirth RA, Greer SL, Albert JM, Young EW, Piette JD. Out-of-pocket spending and medication adherence among dialysis patients in twelve countries. Health Aff. 2008;27(1):89鈥?02. CrossRef 31. T酶ttenborg S, Topp M, Ingebrigtsen TS, Lange P. Physicians should increase focus on poor medicine adherence among chronically ill patients (Danish title: L忙ger b酶r 酶ge fokus p氓 medicinadh忙rens blandt kronisk syge). / Ugeskr Laeger. 2013 [e-pub ahead of print]. Available at: 5130287.pdf" class="a-plus-plus">http://ugeskriftet.dk/files/ugeskriftet.dk/vp05130287.pdf. Accessed August 24, 2014. 32. White P, Thornton H, Pinnock H, Georgopoulou S, Booth HP. Overtreatment of COPD with inhaled corticosteroids鈥搃mplications for safety and costs: cross-sectional observational study. PLoS One. 2013;8(10):e75221. 5221" target="_blank" title="It opens in new window">CrossRef